Increased α3-fucosylation of α1-acid glycoprotein in Type I diabetic patients is related to vascular function

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Glycoconjugate Journal

• Publication date

  2001-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1023/A:1012412908983
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Diabetes and cardiovascular disease

  2000cited by this paper
• Plasma concentration of C-reactive protein is increased in Type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation

  1999influential reference
• Diabetes and cardiovascular disease.

  1999cited by this paper
• Severe rheumatoid arthritis prohibits the pregnancy-induced decrease in alpha3-fucosylation of alpha1-acid glycoprotein.

  1998cited by this paper
• Severe rheumatoid arthritis prohibits the pregnancy-induced decrease in α3-fucosylation of α1-acid glycoprotein

  1998influential reference
• α1-Acid glycoprotein reduces local and remote injuries after intestinal ischemia in the rat.

  1997cited by this paper
• Acceptor specificity of GDP-Fuc:Gal beta 1-->4GlcNAc-R alpha 3-fucosyltransferase VI (FucT VI) expressed in insect cells as soluble, secreted enzyme.

  1997cited by this paper
• Glycosylation of α1-acid glycoprotein in inflammatory disease: analysis by high-pH anion-exchange chromatography and concanavalin A crossed affinity immunoelectrophoresis

  1997cited by this paper
• A missense mutation in the FUT6 gene results in total absence of alpha3-fucosylation of human alpha1-acid glycoprotein.

  1996cited by this paper
• Glycosylation of alpha 1-acid glycoprotein in septic shock: changes in degree of branching and in expression of sialyl Lewis(x) groups.

  1996cited by this paper
• Oral estrogen treatment induces a decrease in expression of sialyl Lewis x on α1 glycoprotein in females and male-to-female transsexuals

  1996cited by this paper
• A Missense Mutation in the FUT6 Gene Results in Total Absence of α3-Fucosylation of Human α1-Acid Glycoprotein*

  1996influential reference
• Glycosylation ofα1 glycoprotein in septic shock: Changes in degree of branching and in expression of sialyl Lewisx groups

  1996cited by this paper
• α1-Acid glycoprotein (orosomucoid): pathophysiological changes in glycosylation in relation to its function

  1995cited by this paper
• Endothelial Dysfunction Precedes Development of Microalbuminuria in IDDM

  1995cited by this paper
• Interleukin‐6‐Type Cytokine‐induced Changes in Acute Phase Protein Glycosylationa a

  1995cited by this paper
• Changes in glycosylation of acute-phase proteins in health and disease: Occurrence, regulation and function

  1994cited by this paper
• Effects of low dose methotrexate therapy on the concentration and the glycosylation of alpha 1-acid glycoprotein in the serum of patients with rheumatoid arthritis: a longitudinal study.

  1994cited by this paper
• Preparative affinity electrophoresis of different glycoforms of serum glycoproteins: Application for the study of inflammation-induced expression of sialyl-Lewisx groups onα1-acid glycoprotein (orosomucoid)

  1994cited by this paper
• Efficient enzymatic synthesis of the sialyl‐LewisX tetrasaccharide

  1993cited by this paper
• Inflammation-induced expression of sialyl Lewis X-containing glycan structures on alpha 1-acid glycoprotein (orosomucoid) in human sera

  1993cited by this paper
• One-step isolation of alpha 1-acid glycoprotein.

  1991cited by this paper
• Multiresidue method for pesticides in drinking water using a graphitized carbon black cartridge extraction and liquid chromatographic analysis.

  1991influential reference
• Acceptor specificity and tissue distribution of three human α‐3‐fucosyltransferases

  1990cited by this paper
• Acceptor specificity and tissue distribution of three human alpha-3-fucosyltransferases.

  1990cited by this paper
• Effects of monocytic products, recombinant interleukin-1, and recombinant interleukin-6 on glycosylation of alpha 1-acid glycoprotein: studies with primary human hepatocyte cultures and rats.

  1989cited by this paper
• Glycosylation of three molecular forms of human alpha 1-acid glycoprotein having different interactions with concanavalin A. Variations in the occurrence of di-, tri-, and tetraantennary glycans and the degree of sialylation.

  1988cited by this paper
• Glycosylation of three molecular forms of human α1‐acid glycoprotein having different interactions with concanavalin A

  1988cited by this paper
• Microheterogeneity of alpha 1-acid glycoprotein in the detection of intercurrent infection in systemic lupus erythematosus.

  1987cited by this paper
• Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes.

  1984cited by this paper
• Diabetes and cardiovascular disease. The Framingham study.

  1979cited by this paper

• SLC35 Transporters: The Missing Link Between Glycosylation and Type 2 Diabetes

  2026cites this paper
• Deciphering disease-specific glycosylation: unraveling diabetes subtypes through serum glycopattern

  2025cites this paper
• N-glycosylation of immunoglobulin A in children and adults with type 1 diabetes mellitus

  2024cites this paper
• Influence of Desialylation on the Drug Binding Affinity of Human Alpha-1-Acid Glycoprotein Assessed by Microscale Thermophoresis

  2024cites this paper
• High-throughput N-glycan analysis in aging and inflammaging: State of the art and future directions.

  2024cites this paper
• A characteristic N-glycopeptide signature associated with diabetic cognitive impairment identified in a longitudinal cohort study.

  2023cites this paper
• N-glycosylation of serum proteins in adult type 1 diabetes mellitus exposes further changes compared to children at the disease onset.

  2023cites this paper
• Fucosylated AGP glycopeptides as biomarkers of HNF1A-Maturity Onset Diabetes of the Young.

  2022cites this paper
• Salivary Glycopatterns as Potential Non-Invasive Biomarkers for Diagnosing and Reflecting Severity and Prognosis of Diabetic Nephropathy

  2022cites this paper
• Glycoprotein analysis using lectin microcolumns and capillary electrophoresis: Characterization of alpha1-acid glycoprotein by combined separation methods.

  2021cites this paper
• Changes in the Expression of Renal Brush Border Membrane N-Glycome in Model Rats with Chronic Kidney Diseases

  2021cites this paper
• N-glycans as functional effectors of genetic and epigenetic disease risk.

  2020cites this paper
• High-throughput and site-specific N-glycosylation analysis of human alpha-1-acid glycoprotein offers a great potential for new biomarker discovery.

  2020cites this paper
• Population pharmacokinetics of gabapentin in patients with neuropathic pain: Lack of effect of diabetes or glycaemic control

  2020cites this paper
• Fibrinogen Fucosylation as a Prognostic Marker of End-Stage Renal Disease in Patients on Peritoneal Dialysis

  2020cites this paper
• Altered N‐glycosylation profiles as potential biomarkers and drug targets in diabetes

  2019cites this paper
• Human disease glycomics: technology advances enabling protein glycosylation analysis – part 2

  2018cites this paper
• A Crude 1-DNJ Extract from Home Made Bombyx Batryticatus Inhibits Diabetic Cardiomyopathy-Associated Fibrosis in db/db Mice and Reduces Protein N-Glycosylation Levels

  2018cites this paper
• Alteration of glycosylation in serum proteins: a new potential indicator to distinguish non-diabetic renal diseases from diabetic nephropathy

  2018cites this paper
• The effect of streptozotocin-induced hyperglycemia on N-and O-linked protein glycosylation in mouse ovary

  2018cites this paper
• Clinical and metabolic factors associated with chronic low-grade inflammation in type 2 diabetic patients

  2016cites this paper
• [Acute-phase serum proteins and adipocytokines in women with type 2 diabetes mellitus: Relationships with body composition and blood glucose fluctuations].

  2016cites this paper
• Glycosylation patterns of kidney proteins differ in rat diabetic nephropathy.

  2015cites this paper
• RNA-seq analysis of glycosylation related gene expression in STZ-induced diabetic rat kidney inner medulla

  2015cites this paper
• Alpha-1-acid glycoprotein as a potential biomarker of breast cancer in at risk individuals.

  2015cites this paper
• Effects of type 1 and type 2 diabetes on the pharmacokinetics of tramadol enantiomers in patients with neuropathic pain phenotyped as cytochrome P450 2D6 extensive metabolizers

  2014cites this paper
• Increased orosomucoid in urine is an independent predictor of cardiovascular and all-cause mortality in patients with type 2 diabetes at 10 years of follow-up.

  2013cites this paper
• A Study of the Effect of Physical Sports Injury on the Glycosylation Patterns of Alpha-1-Acid Glycoprotein.

  2013cites this paper
• Glycan alterations of serum proteins as tumour markers. Prostate-specific antigen in prostate cancer and acute-phase proteins in pancreatic cancer

  2011cites this paper
• Liver proteins as sensor of human malignancies and inflammation

  2010cites this paper
• Glycosylation of liver acute‐phase proteins in pancreatic cancer and chronic pancreatitis

  2010cites this paper
• Expression and structural-functional alterations of α-1-acid glycoprotein at the pathological state

  2010cites this paper
• Isoform differentiation of intact AGP from human serum by capillary electrophoresis–mass spectrometry

  2010cites this paper
• Fehérjék nemkovalens komplexképzésének és glikozilációjának tömegspektrometriás vizsgálata

  2009influential citation
• Detection of global glycosylation changes of serum proteins in type 1 diabetes using a lectin panel and multivariate data analysis.

  2008cites this paper
• Mass spectrometric and linear discriminant analysis of N-glycans of human serum alpha-1-acid glycoprotein in cancer patients and healthy individuals.

  2008cites this paper
• Glycosylation and ligand-binding activities of rat plasma fibronectin during liver regeneration after partial hepatectomy.

  2008cites this paper
• Analysis of N-glycan in serum glycoproteins from db/db mice and humans with type 2 diabetes.

  2007cites this paper
• Fucosylation of serum α1-acid glycoprotein in rheumatoid arthritis patients treated with infliximab

  2007cites this paper
• Interleukin‐1β induces sialyl Lewis X on hepatocellular carcinoma HuH‐7 cells via enhanced expression of ST3Gal IV and FUT VI gene

  2006cites this paper
• Fucosylation in prokaryotes and eukaryotes.

  2006cites this paper
• Glycosylation of site-specific glycans of alpha1-acid glycoprotein and alterations in acute and chronic inflammation.

  2005cites this paper
• Gene expression profiles of peripheral blood cells in type 2 diabetes and nephropathy in Asian Indians

  2004cites this paper
• Acute-phase proteins and microalbuminuria among patients with type 2 diabetes.

  2004cites this paper
• Acute-phase proteins among patients with type 1 diabetes.

  2003cites this paper
• Altered glycosylation of α1-acid glycoprotein in patients with inflammation and diabetes mellitus

  2003cites this paper